All good with no current downsides - Sr. Director bei BrightSpring Health Services: Mitarbeiterbewertung

5,0
15. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Company is very focused on investing in to building AI products in house.

Kontras

Nothing to complain, great msnagement

Mehr Bewertungen zu BrightSpring Health Services entdecken

5,0
4. Juli 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great Experience Highly tenured leadership Unlimited PTO

Kontras

No 401k Poor healthcare benefits

1,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Your undervalued and underpaid coworkers

Kontras

The manipulation Pharmerica uses to ensure the compensation is not accurate! The market moved and the company didn’t, the benchmark is outdated but told verbatim "we are NOT a priority" The company prioritized cost control over market competitiveness

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle